Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

117 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Strategies for Promoting Research among Endocrinologists in Private Practice.
Chopra A, Xavier D, George B, Bantwal G, Sahay R, Kumar KH, Madhu SV, Bhattacharya S. Chopra A, et al. Among authors: bantwal g. Indian J Endocrinol Metab. 2023 Jan-Feb;27(1):28-31. doi: 10.4103/2230-8210.370909. Epub 2023 Mar 3. Indian J Endocrinol Metab. 2023. PMID: 37215263 Free PMC article. No abstract available.
Expert Opinion on the Diagnosis and Management of Male Hypogonadism in India.
Kalra S, Jacob J, Unnikrishnan AG, Bantwal G, Sahoo A, Sahay R, Jindal S, Agrawal MS, Kapoor N, Saboo B, Tiwaskar M, Kochhar K. Kalra S, et al. Among authors: bantwal g. Int J Endocrinol. 2023 Feb 22;2023:4408697. doi: 10.1155/2023/4408697. eCollection 2023. Int J Endocrinol. 2023. PMID: 36876281 Free PMC article. Review.
Barriers and solutions to diabetes management: An Indian perspective.
Wangnoo SK, Maji D, Das AK, Rao PV, Moses A, Sethi B, Unnikrishnan AG, Kalra S, Balaji V, Bantwal G, Kesavadev J, Jain SM, Dharmalingam M. Wangnoo SK, et al. Among authors: bantwal g. Indian J Endocrinol Metab. 2013 Jul;17(4):594-601. doi: 10.4103/2230-8210.113749. Indian J Endocrinol Metab. 2013. PMID: 23961474 Free PMC article.
Comparison of insulin degludec/insulin aspart and biphasic insulin aspart 30 in uncontrolled, insulin-treated type 2 diabetes: a phase 3a, randomized, treat-to-target trial.
Fulcher GR, Christiansen JS, Bantwal G, Polaszewska-Muszynska M, Mersebach H, Andersen TH, Niskanen LK; BOOST: Intensify Premix I Investigators. Fulcher GR, et al. Among authors: bantwal g. Diabetes Care. 2014 Aug;37(8):2084-90. doi: 10.2337/dc13-2908. Epub 2014 May 8. Diabetes Care. 2014. PMID: 24812432 Clinical Trial.
117 results